These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 33281823)

  • 1. The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside.
    Liu T; Li S; Ying S; Tang S; Ding Y; Li Y; Qiao J; Fang H
    Front Immunol; 2020; 11():594735. PubMed ID: 33281823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art.
    Bernardini N; Skroza N; Tolino E; Mambrin A; Anzalone A; Balduzzi V; Colapietra D; Marchesiello A; Michelini S; Proietti I; Potenza C
    Int J Dermatol; 2020 Apr; 59(4):406-411. PubMed ID: 31663126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris.
    Feldmeyer L; Mylonas A; Demaria O; Mennella A; Yawalkar N; Laffitte E; Hohl D; Gilliet M; Conrad C
    JAMA Dermatol; 2017 Apr; 153(4):304-308. PubMed ID: 28122069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Learning From Success and Failure: Biologics for Non-approved Skin Diseases.
    Speeckaert R; Lambert J; van Geel N
    Front Immunol; 2019; 10():1918. PubMed ID: 31440261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.
    Toussirot E
    Inflamm Allergy Drug Targets; 2012 Apr; 11(2):159-68. PubMed ID: 22280236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.
    Fletcher JM; Moran B; Petrasca A; Smith CM
    Clin Exp Immunol; 2020 Aug; 201(2):121-134. PubMed ID: 32379344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of IL-17 in psoriasis.
    Malakouti M; Brown GE; Wang E; Koo J; Levin EC
    J Dermatolog Treat; 2015 Feb; 26(1):41-4. PubMed ID: 24552504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
    Guttman-Yassky E; Krueger JG
    Curr Opin Immunol; 2017 Oct; 48():68-73. PubMed ID: 28869867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
    Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
    Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis and other Th17-mediated skin diseases.
    Tokura Y; Mori T; Hino R
    J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti IL-17 in psoriasis.
    Ly K; Smith MP; Thibodeaux Q; Reddy V; Liao W; Bhutani T
    Expert Rev Clin Immunol; 2019 Nov; 15(11):1185-1194. PubMed ID: 31603358
    [No Abstract]   [Full Text] [Related]  

  • 12. p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation.
    Zheng T; Zhao W; Li H; Xiao S; Hu R; Han M; Liu H; Liu Y; Otsu K; Liu X; Huang G
    Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Th17 in the pathogenesis of cutaneous inflammatory diseases.
    Chiricozzi A; Zhang S; Dattola A; Gabellini M; Chimenti S; Nistico SP
    J Biol Regul Homeost Agents; 2012; 26(3):313-8. PubMed ID: 23034250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 17A: toward a new understanding of psoriasis pathogenesis.
    Lynde CW; Poulin Y; Vender R; Bourcier M; Khalil S
    J Am Acad Dermatol; 2014 Jul; 71(1):141-50. PubMed ID: 24655820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of the role of interleukin-17 and the interleukin-20 family in inflammatory allergic skin diseases.
    Hofmann MA; Kiecker F; Zuberbier T
    Curr Opin Allergy Clin Immunol; 2016 Oct; 16(5):451-7. PubMed ID: 27490126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-23/IL-17 axis in spondyloarthritis-bench to bedside.
    Raychaudhuri SP; Raychaudhuri SK
    Clin Rheumatol; 2016 Jun; 35(6):1437-41. PubMed ID: 27075462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th17 cells: a new therapeutic target in inflammatory dermatoses.
    Asarch A; Barak O; Loo DS; Gottlieb AB
    J Dermatolog Treat; 2008; 19(6):318-26. PubMed ID: 18626814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic Abnormalities of Keratinocytes Initiate Skin Inflammation through the IL-23/T17 Axis in a MALT1-Dependent Manner.
    Zhang S; Wang M; Wang C; Wang G; Sun K; Xiong S; Cheng L; Yang D; Lin X; Zhao X
    J Immunol; 2021 Feb; 206(4):839-848. PubMed ID: 33419765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.